PCAR-119 Bridge Immunotherapy

· PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PCAR-119 Bridge Immunotherapy, covering 2016-12-06 to 2016-12-06. Get the full timeline:

Most recent: Clinical Trial Update: PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma [Phase 1, Phase 2]

See pricing